{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:45:03Z","timestamp":1791308703623,"version":"4.3.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1004084","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T21:05:53Z","timestamp":1398373553000},"page":"e1004084","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants"],"prefix":"10.1371","volume":"10","author":[{"given":"Emilie","family":"Sundqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Warnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaura","family":"Lima Bomfim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fogdell-Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Bach","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hillert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"International Multiple Sclerosis Genetics Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette B.","family":"Oturai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Hemme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kockum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"ref1","first-page":"93","article-title":"Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin&apos;s disease","volume":"81","author":"KE Astrom","year":"1958","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","article-title":"Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy","volume":"1","author":"BL Padgett","year":"1971","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","article-title":"Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project","volume":"10","author":"KR Carson","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMc1211805","article-title":"PML in a patient treated with fumaric acid","volume":"368","author":"U Ermis","year":"2013","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.3414","article-title":"Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants","volume":"22","author":"C Piccinni","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/pds.3320","article-title":"Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)","volume":"21","author":"N Schmedt","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJMc1215357","article-title":"PML in a patient treated with dimethyl fumarate from a compounding pharmacy","volume":"368","author":"BW van Oosten","year":"2013","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"G Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","article-title":"Anti-JC virus antibodies: implications for PML risk stratification","volume":"68","author":"L Gorelik","year":"2010","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcv.2011.10.003","article-title":"Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma","volume":"53","author":"T Plavina","year":"2012","journal-title":"J Clin Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ana.22606","article-title":"Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1","volume":"70","author":"C Bozic","year":"2011","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1352458511435105","article-title":"Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab","volume":"18","author":"PS Sorensen","year":"2012","journal-title":"Mult Scler"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/jnnp-2012-304332","article-title":"Changes to anti-JCV antibody levels in a Swedish national MS cohort","volume":"84","author":"C Warnke","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0b013e3182583022","article-title":"Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort","volume":"78","author":"AK Trampe","year":"2012","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00415-012-6487-5","article-title":"Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy","volume":"259","author":"O Outteryck","year":"2012","journal-title":"J Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2010.09.013","article-title":"Detection and quantitation of infectious human adenoviruses and JC polyomaviruses in water by immunofluorescence assay","volume":"171","author":"B Calgua","year":"2011","journal-title":"J Virol Methods"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/1352458513475489","article-title":"An assay to quantify species-specific anti-JC virus antibody levels in MS patients","volume":"19","author":"C Warnke","year":"2013","journal-title":"Mult Scler"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.23893","article-title":"JC virus antibody status underestimates infection rates","volume":"74","author":"JR Berger","year":"2013","journal-title":"Ann Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/iji.12029","article-title":"16(th) IHIW: global distribution of extended HLA haplotypes","volume":"40","author":"M Askar","year":"2013","journal-title":"Int J Immunogenet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0039.2009.01215.x","article-title":"HLA-B51 and haplotypic diversity of B-Cw associations: implications for matching in unrelated hematopoietic stem cell transplantation","volume":"73","author":"F Bettens","year":"2009","journal-title":"Tissue Antigens"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.humimm.2005.11.006","article-title":"The haplotype structure of the human major histocompatibility complex","volume":"67","author":"CA Alper","year":"2006","journal-title":"Hum Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1128\/JVI.02803-12","article-title":"T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donors","volume":"87","author":"I Jelcic","year":"2013","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.23893","article-title":"JC virus antibody status underestimates infection rates","volume":"74","author":"JR Berger","year":"2013","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMc1214233","article-title":"JC viremia in natalizumab-treated patients with multiple sclerosis","volume":"368","author":"EO Major","year":"2013","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virol.2010.12.015","article-title":"Induction and function of virus-specific CD4+ T cell responses","volume":"411","author":"JK Whitmire","year":"2011","journal-title":"Virology"},{"key":"ref26","unstructured":"Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, et al. (2013) JCV Antibody Index Stratifies PML Risk in Natalizumab-Treated MS Patients. In: The 27th Annual Meeting of the Consortium of Multiple Sclerosis Centers. Orlando, Florida, United States. pp. Paper1642."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/infdis\/jir198","article-title":"Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity","volume":"204","author":"L Gorelik","year":"2011","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir256","article-title":"Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients","volume":"204","author":"CE Reid","year":"2011","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/13550280903552438","article-title":"Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy","volume":"16","author":"S Gheuens","year":"2010","journal-title":"J Neurovirol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1003147","DOI":"10.1371\/journal.pgen.1003147","article-title":"A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1)","volume":"9","author":"R Rubicz","year":"2013","journal-title":"PLoS Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-3083.2011.02568.x","article-title":"HLA class II alleles and chronic hepatitis C virus infection","volume":"74","author":"LO Cangussu","year":"2011","journal-title":"Scand J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1093\/hmg\/ddr383","article-title":"Genome-wide association study of HPV seropositivity","volume":"20","author":"D Chen","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ng.348","article-title":"A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians","volume":"41","author":"Y Kamatani","year":"2009","journal-title":"Nat Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/gene.2010.1","article-title":"New genetic associations detected in a host response study to hepatitis B vaccine","volume":"11","author":"S Davila","year":"2010","journal-title":"Genes Immun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1093\/hmg\/ddr302","article-title":"A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region","volume":"20","author":"E Png","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/ng.960","article-title":"Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1","volume":"43","author":"CC Khor","year":"2011","journal-title":"Nat Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.1143767","article-title":"A whole-genome association study of major determinants for host control of HIV-1","volume":"317","author":"J Fellay","year":"2007","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"V Kumar","year":"2011","journal-title":"Nat Genet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e36779","DOI":"10.1371\/journal.pone.0036779","article-title":"Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis","volume":"7","author":"J Link","year":"2012","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1212\/WNL.0b013e3181b59c40","article-title":"Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis","volume":"73","author":"AK Hedstrom","year":"2009","journal-title":"Neurology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/1352458510394701","article-title":"A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis","volume":"17","author":"C Holmen","year":"2011","journal-title":"Mult Scler"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","article-title":"HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation","volume":"39","author":"O Olerup","year":"1992","journal-title":"Tissue Antigens"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/bioinformatics\/btr061","article-title":"HLA*IMP\u2013an integrated framework for imputing classical HLA alleles from SNP genotypes","volume":"27","author":"AT Dilthey","year":"2011","journal-title":"Bioinformatics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"S Sawcer","year":"2011","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e1002877","DOI":"10.1371\/journal.pcbi.1002877","article-title":"Multi-Population Classical HLA Type Imputation","volume":"9","author":"A Dilthey","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"AH Beecham","year":"2013","journal-title":"Nat Genet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/bioinformatics\/btm108","article-title":"GenABEL: an R library for genome-wide association analysis","volume":"23","author":"YS Aulchenko","year":"2007","journal-title":"Bioinformatics"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"AL Price","year":"2006","journal-title":"Nat Genet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref50","unstructured":"R Development Core Team (2008) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing."}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1004430","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T00:00:00Z","timestamp":1410134400000}}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1004084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:43:50Z","timestamp":1588963430000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1004084"}},"subtitle":[],"editor":[{"given":"Walter J.","family":"Atwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1004084","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.ppat.1004430","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}